latest update:
[TrialBase DB]

trial summary · NCT07322133

Dopamine vs. Norepinephrine for Hypotension in Neonates With Pulmonary Hypertension (DONE)

Dopamine vs. Norepinephrine in Term and Late Preterm Neonates With Hypoxemic Respiratory Failure and Systemic Hypotension Due to Pulmonary Hypertension: A Pilot Trial

Trial record from the TrialBase DB dataset, status RECRUITING, condition Hypotension and Shock, sponsored by University of California, Davis. Facts below are exported values from the current release, not inferred or edited prose.

registry NCT07322133phase PHASE4enrollment 30start 2026-10-30

Summary

The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.

This pilot randomized clinical trial compares dopamine and norepinephrine as first-line vasoactive therapies in term and late preterm neonates with pulmonary hypertension associated with hypoxemic respiratory failure and systemic hypotension. Systemic hypotension is a common and clinically significant complication of persistent pulmonary hypertension of the newborn (PPHN) and frequently requires vasopressor support to maintain adequate systemic perfusion. Dopamine is commonly used in this setting; however, prior animal experimental and clinical data suggest it may increase pulmonary vascular resistance, potentially worsening right ventricular afterload and hypoxemia. Norepinephrine may preferentially increase systemic vascular resistance with less effect on the pulmonary circulation. This study evaluates short-term hemodynamic and oxygenation responses following initiation of dopamine or norepinephrine.

Source record: https://clinicaltrials.gov/study/NCT07322133

Facts

registry idNCT07322133
primary registryclinicaltrials-gov
recruitment statusRECRUITING
phasePHASE4
study typeINTERVENTIONAL
lead conditionHypotension and Shock
sponsorUniversity of California, Davis
sponsor classOTHER
enrollment30
start date2026-10-30
primary completion2027-06-30
completion2027-06-30
results postednot reported

Conditions

  • Hypotension and Shock
  • Pulmonary Hypertension of the Newborn (PPHN)
  • Hypoxemic Respiratory Failure

Interventions

  • Dopamine administration
  • Norepinephrine

Countries

  • United States

Intervention types: DRUG

Work with this record